What Is the Growth Outlook for the Global Prostate Cancer PSMA-PET Imaging Agents Market (2025–2034)?
Intel Market Research, the global Prostate Cancer PSMA-PET Imaging Agents market was valued at USD 1.12 billion in 2026 and is projected to reach USD 3.47 billion by 2034, growing at an impressive CAGR of 16.9% during the forecast period (2025-2034). This robust growth trajectory reflects the rising clinical adoption of precision diagnostic tools in prostate cancer management combined with significant technological advancements in radiopharmaceuticals.